SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

CytoDyn Inc.
Date: Nov. 26, 2025 · CIK: 0001175680 · Accession: 0001104659-25-116466

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-291263

Date
November 26, 2025
Author
Robert E. Hoffman
Form
CORRESP
Company
CytoDyn Inc.

Letter

​ November 26, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Lauren Hamill ​ Re: CytoDyn Inc. Registration Statement on Form S-3 File No. 333-291263 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-3 filed on November 4, 2025 (Registration No. 333-291263) (the “Registration Statement”) so that the Registration Statement shall become effective at noon Eastern Time on December 2, 2025, or as soon as possible thereafter. We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing. If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you. ​ ​ ​ ​ ​ ​ Very truly yours, ​ ​ ​ ​ ​ /s/ Robert E. Hoffman ​ ​ Robert E. Hoffman ​ ​ Chief Financial Officer ​

Show Raw Text
CORRESP
 1
 filename1.htm

 ​ November 26, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Lauren Hamill ​ Re: CytoDyn Inc. Registration Statement on Form S-3 File No. 333-291263 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-3 filed on November 4, 2025 (Registration No. 333-291263) (the “Registration Statement”) so that the Registration Statement shall become effective at  noon Eastern Time on December 2, 2025, or as soon as possible thereafter. We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing. If you have any questions about the foregoing request, please contact our counsel, Mary  Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you. ​ ​ ​ ​ ​ ​ Very truly yours, ​ ​ ​ ​ ​ /s/ Robert E. Hoffman ​ ​ Robert E. Hoffman ​ ​ Chief Financial Officer ​